Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Decraecker

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal for Immunotherapy of Cancer|January 4, 2025
Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitorsJulien Taieb, Margherita Ambrosini, Emily Alouani, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2025
Prognostic impact of the BRAF V600E mutation in patients with MSI-high metastatic colorectal cancer treated with immune checkpoint inhibitorsClaire Gallois, Margherita Ambrosini, Sara Lonardi, et al.
Journal for Immunotherapy of Cancer|October 30, 2025
Efficacy of immunotherapy in gastrointestinal (GI) tumors with mismatch repair deficient (MMRd) unusual phenotype: an AGEO real-world studyEmily Alouani, Julien Taieb, David Tougeron, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 5, 2024
Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver (AFEF)Cindy Neuzillet, Marie Decraecker, Hélène Larrue, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2025
Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO studyIona Campo-Le-Brun, Emma Grapinet, Valerie Aurillac, et al.
The Journal of Clinical Investigation|April 23, 2024
Human NLRC4 expression promotes cancer survival and associates with type I interferon signaling and immune infiltrationCharlotte Domblides, Steven Crampton, Hong Liu, et al.
JHEP Reports : Innovation in Hepatology|June 11, 2026
Second-Line Practices in the Era of Immunotherapy in HCC: The CHIEF CohortMarie Decraecker, Héloïse Bourien, Elhadji Malick Thiam, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 26, 2025
Diagnostic Performance of LIVERFASt as a Non-invasive Liver Fibrosis Test: Data from Three Cohorts of Patients with Metabolic Dysfunction-associated Steatotic Liver DiseaseNaim Alkhouri, Parvez Mantry, Humberto C Gonzalez, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal for Immunotherapy of Cancer|January 4, 2025
Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitorsJulien Taieb, Margherita Ambrosini, Emily Alouani, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2025
Prognostic impact of the BRAF V600E mutation in patients with MSI-high metastatic colorectal cancer treated with immune checkpoint inhibitorsClaire Gallois, Margherita Ambrosini, Sara Lonardi, et al.
Journal for Immunotherapy of Cancer|October 30, 2025
Efficacy of immunotherapy in gastrointestinal (GI) tumors with mismatch repair deficient (MMRd) unusual phenotype: an AGEO real-world studyEmily Alouani, Julien Taieb, David Tougeron, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 5, 2024
Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver (AFEF)Cindy Neuzillet, Marie Decraecker, Hélène Larrue, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2025
Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO studyIona Campo-Le-Brun, Emma Grapinet, Valerie Aurillac, et al.
The Journal of Clinical Investigation|April 23, 2024
Human NLRC4 expression promotes cancer survival and associates with type I interferon signaling and immune infiltrationCharlotte Domblides, Steven Crampton, Hong Liu, et al.
JHEP Reports : Innovation in Hepatology|June 11, 2026
Second-Line Practices in the Era of Immunotherapy in HCC: The CHIEF CohortMarie Decraecker, Héloïse Bourien, Elhadji Malick Thiam, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 26, 2025
Diagnostic Performance of LIVERFASt as a Non-invasive Liver Fibrosis Test: Data from Three Cohorts of Patients with Metabolic Dysfunction-associated Steatotic Liver DiseaseNaim Alkhouri, Parvez Mantry, Humberto C Gonzalez, et al.
Pageof 3